For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Scope of the Report:
In the last several years, Global market of Wound Care Biologics developed rapidly. North America region is the largest supplier of Wound Care Biologics, with a production value market share nearly 57.81%. Europe is the second largest supplier of Wound Care Biologics, enjoying production value market share nearly 29.10%.
North America is also the largest consumption place, with a consumption market share nearly 56.97%. Following North America, Europe is the second largest consumption place with the consumption market share of 27.29%.
With the development of medical technology level, more and more companies participate in this industry.
The worldwide market for Wound Care Biologics is expected to grow at a CAGR of roughly 10.5% over the next five years, will reach 4690 million US$ in 2024, from 2580 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Wound Care Biologics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Smith & Nephew
- Organogenesis
- MiMedx
- Integra
- Osiris
- Derma Sciences, Inc
- Soluble Systems
- Amnio Technology, LLC
- Medline
- Skye® Biologics
- Alphatec Spine,Inc.
- Pinnacle Transplant Technologies
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
Market Segment by Applications, can be divided into
- Acute Wounds
- Chronic Wounds
- Surgical Wounds
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Wound Care Biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Wound Care Biologics, with price, sales, revenue and global market share of Wound Care Biologics in 2017 and 2018.
Chapter 3, the Wound Care Biologics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Wound Care Biologics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Wound Care Biologics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Wound Care Biologics sales channel, distributors, customers, research findings and conclusion, appendix and data source.